Visante Announces New Addition to Team: Infusion Expert, Jeff Prosch

Visante is excited to announce that infusion expert, Jeff Prosch, has joined our team. Jeff’s experience in home infusion and site of care strategies will help our hospital and health system clients to create or optimize their infusion strategies for improve patient care and financial performance. Read More >>

Meet PharmaComplete’s Newest Addition: Leanne Haley-Brown

Leanne has been in the pharmacy industry for over 35 years. As an Independent Pharmacy owner, she grew a successful business from the bottom up. She gained extensive experience in business development, operations, compliance, insurance self-contracting and commercial payer credentialing. She spent 21 years providing unique dispensing services such as SYNC and packaging long before […]

Happy Thanksgiving!

On behalf of everyone at RXinsider, we wish you a healthy and happy Thanksgiving!

The 20Ways WINTER Hospital 2022 Issue is Here: Health Systems

RXinsider launches 20Ways Winter Hospital, the Health Systems and Infusion edition of 20Ways.  20Ways is published on a quarterly basis, educating pharmacy managers on 20 unique products and services that aim to improve patient care and a pharmacy’s financial bottom line. This issue will showcase Refrigeration, featuring a Q&A from Industry Expert, Dennis Smith, a Market […]

TouchPoint Medical to Exhibit at ASHP: Visit Us!

Event Date | Dec 4th-8th 2022 ASHP is an opportunity to meet experts from around the world on issues relevant to contemporary pharmacy practices. The 57th midyear meeting will be held in Las Vegas, Nevada at the Mandalay Bay Convention Center. Visit TouchPoint Medical, Booth # 722 Address of Event Mandalay Bay Convention Center Las […]

FDA restricts thyroid compounding options

FDA has declared desiccated thyroid extract (DTE) to be a biologic drug and therefore ineligible for compounding. In a September 16 letter to National Association of Boards of Pharmacy CEO Al Carter, FDA states that DTE products “can put patients at harm” and that “therapies containing DTE are biological products subject to licensure under Section […]

SUBSCRIBE

Name
Subscription Choices
Checkboxes

Request information from INDUSTRY UPDATE: FDA Provides for More Treatments for Dogs and Cats to Qualify for Minor Use Status

Name
Address
Subscribe